A Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of PRF110 in Bunionectomy Surgery
Status:
Unknown status
Trial end date:
2017-06-01
Target enrollment:
Participant gender:
Summary
PRF110 is new extended release oily solution formulation of ropivacaine that is intended for
local infiltration into surgical wounds. The purpose of this study is to determine the safety
and early efficacy of PRF110 in bunionectomy surgery, to measure the pharmacokinetic profile
of PRF110 over 72 hours and evaluate the duration of analgesia witnessed in the surgical
setting.